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Synthesis of (+)-(1R, 2S, 9S, 9aR)-Octahydro-1H-
pyrrolo[1,2-a]azepine-1,2,9-triol: A Potential Glycosidase 
Inhibitor 
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Wales, 2522, Australia 
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Abstract: The title compound was prepared as a potential glycosidase inhibitor.  Key 
steps in the synthesis are vinyl epoxide aminolysis, ring-closing metathesis, cis-
dihydroxylation and then ring closure.  
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Polyhydroxylated pyrrolizidine [e.g. (+)-alexine (1)] and indolizidine [e.g. (-)-
swainsonine (2)] alkaloids are potent glycosidase inhibitors,1,2  making these 
compounds good lead compounds for the development of new drugs for the treatment 
of viral infections, cancer and diabetes.3,4  Consequently a substantial volume of 
research has been conducted, aimed at the synthesis of these alkaloids and their 
analogues.1,2,4,5  While compounds with the 5,5- and 5,6-heterocyclic ring system 
found in these natural products have been extensively studied, we were surprised to 
discover that analogues with the corresponding 5,7-heterocyclic ring system (i.e. 1H-
pyrrolo[1,2-a]azepines) remain relatively unexplored.  Recently we reported an 
asymmetric total synthesis of (-)-swainsonine (2) and two of its diastereomers, 1,2-
diepi-swainsonine and 1,2,8a-triepi-swainsonine.6  The non-chiral pool route used in 
that synthesis was very flexible, and we envisaged that it could be readily applied to 
polyhydroxylated systems of other ring size combinations, such as the 5,7-











(-)-swainsonine (2)  
 
Results and Discussion 
The starting vinyl epoxide (-)-(2S, 3R)-3 was prepared from the corresponding 
Sharpless epoxy alcohol (92 % ee) via Swern oxidation followed by a Wittig-
olefination reaction.6-9  
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A solution of the vinyl epoxide (-)-3 and allylamine (3 equiv) in acetonitrile was 
heated at 120 oC in a closed teflon vessel in a microwave reactor (Milestone, ETHOS 
SEL), using LiOTf (1 equiv) as a catalyst.8   This gave only amino alcohol (-)-46,8 via 
an SN2 ring opening, with no evidence of any other regio/stereoisomers.  After 
protection of (-)-4 as its N-Boc derivative, ring-closing metathesis using 5 mol % 
benzylidene-bis-(tricyclohexylphosphine)dichlororuthenium (Grubbs' catalyst) in 
refluxing CH2Cl2 at high dilution (~4 mM)
6,8  for 20 h, gave the 2,5-dihydropyrrole (-
)-5 in excellent yield (85% overall for the 2 steps).  Compound (-)-5 was treated with 
5 mol % K2OsO4.2H2O and NMO (2.1 equiv), to effect cis-dihydroxylation of the 
double bond, giving triol (-)-6 also in excellent yield (96%).  Only one diastereomeric 
product was isolated, which was expected to arise from delivery of the two hydroxyl 
groups to the least hindered face of the 3,4-double bond in (-)-5.6  Triol (-)-6 was then 
reacted with NaH and benzyl bromide, together with a catalytic amount of nBu4NI.
10  
This gave the desired tri-O-benzyl derivative (-)-7 in 55 % yield.  The low yield was 
due primarily to the formation of an unwanted oxazolidinone (+)-8, which was 
isolated in 21 % yield.  No attempt was made to optimise the conditions of this 
reaction to lower the amount of (+)-8 being formed, but it is likely that a higher 
concentration of nBuNI and/or benzyl bromide would improve the ratio of 
compounds (-)-7 and (+)-8 in the reaction.  Compound (-)-7 was then reacted with 
trifluoroacetic acid to accomplish N-deprotection.  By using anisole as a cation trap, 
the p-methoxybenzyl (PMB) protecting group was also removed, resulting in the 
formation of amino alcohol (+)-9 in high yield (96%).6  Formation of the 7-membered 
azepine ring, was achieved by treating (+)-9 with carbon tetrabromide and 
triphenylphosphine in the presence of triethylamine at 4 oC for 20 h.  This gave a 
moderate yield (51 %) of the protected bicyclic compound (+)-10, but it should be 
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noted that this reaction was only performed once, and higher yields may be achieved 
with further optimisation (e.g. longer reaction time).  Finally, O-benzyl removal by 
catalytic hydrogenolysis, using PdCl2 under an atmosphere of H2 (1 atm), gave (+)-
11.HCl in excellent yield, which was purified by ion-exchange chromatography to 
give the free amine (+)-11 as a white solid (m. p. 100-104 oC,  []D25:  +60.3 (c 0.46, 
MeOH)) in 98% yield.  
 
Conclusions 
In summary, the synthesis of a potential glycosidase inhibitor, based on a novel 1H-
pyrrolo[1,2-a]azepine structure has been achieved.  We believe the method is flexible 
enough to allow the synthesis of many analogues, including those with different 
stereochemistries and/or larger ring systems simply by varying the vinyl epoxide 
stereochemistry, and/or epoxide side-chain length.  Furthermore, this method could 
potentially be extended to the synthesis of the key 1H-pyrrolo[1,2-a]azepine core of 
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Scheme 1. Reagents and conditions: (a) allylamine (3 equiv), LiOTf (1 equiv), 
CH3CN, 120 
oC, microwave, 1 h; (b) (Boc)2O (2 equiv), Et3N (2 equiv), Et2O, rt, 18 
h; (c) Cl2(Cy3P)2Ru=CHPh (5 mol%), CH2Cl2 reflux, 20 h; (d) K2OsO4.2H2O (5 
mol%), NMO (2.2 equiv), acetone, water, rt, 20 h; (e) NaH (6 equiv), BnBr (5.5 
equiv), nBu4NI (0.3 equiv), THF, rt, 3 d; (f) TFA (10 equiv), anisole (10 equiv), 
CH2Cl2, rt, 2 h; (g) PPh3
 (2.5 equiv), CBr4 (2.5 equiv), NEt3 (40 equiv) CH2Cl2 4 
oC, 







(3S,4S)-8-[(4-Methoxyphenyl)methoxy]-3-(2-propenylamino)-1-octen-4-ol (4).  
The vinyl epoxide 36-9 (500 mg, 1.90 mmol) was dissolved in CH3CN (3 mL) then 
allylamine (328 mg, 5.718 mmol) and LiOTf (297 mg, 1.90 mmol) were added.  The 
mixture was placed in a teflon tube with a 100 bar pressure cap, then heated in a 
microwave reactor at 120 oC for 1h.  After cooling all volatiles were removed  in 
vacuo to give an oil.  Pure product was obtained by column chromatography on flash 
silica gel (increasing polarity from 5 % to 15 % MeOH in DCM as eluant), which 
gave the title compound (591 mg, 1.85 mmol, 97 %) as a pale yellow oil. 
[]D29:  -7 (c 1.3, CHCl3). MS (CI+) m/z 320 (100 %) (M+1), HRMS (CI+) found 
320.2238, calc for C19H30NO3 320.2226 (M+1). H (300 MHz, CDCl3): 1.20-1.70 
(6H, m, H5, H6 and H7), 2.43 (2H, br.s, NH and OH), 2.77 (1H, t, J=8.7 Hz, H3), 
3.07 (1H, ddt, J=13.8. 6.3, 1.2 Hz, H1'a), 3.20-3.50 (5H, m, H4, H8, H1'b), 3.80 (3H, 
s, OCH3), 4.42 (2H, s, OCH2Ar), 5.05-5.30 (4H, m, H1 and H3'), 5.49 (1H, ddd, 
J=16.8, 10.2, 8.4 Hz, H2), 5.87 (1H, m, H2'), 6.87 (2H, dt, J=9.0, 2.7 Hz, 2 x ArCH), 
7.25 (2H, dt, J=9.0, 2.7 Hz, 2 x ArCH). C (75 MHz, CDCl3):  22.3 (t, C6), 29.7, 33.4 
(t, C5 and C7), 49.2 (t, C1'), 55.2 (q, OCH3), 66.4 (d, C3), 70.0 (t, C8), 72.5 (t, 
OCH2Ar), 72.6 (d, C4), 113.7 (d, 2 x ArCH), 116.2, 118.5 (t, C1 and C3'), 129.2 (d, 2 
x ArCH), 130.6 (s, ArC), 136.4, 136.8 (d, C2 and C2'), 159.0 (s, ArC). 
 
N-Boc derivative of 4 (1,1-Dimethylethyl N-[(1S,2S)-1-ethenyl-2-hydroxy-6-[(4-
methoxyphenyl)methoxy]hexyl]-N-(2-propenyl)-carbamate. 
The amine 4 (110 mg, 0.344 mmol) was dissolved in Et2O (10 mL), then 
triethylamine (75 mg, 0.776 mmol) and di-tert-butyldicarbonate (161 mg, 0.776 
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mmol) were added.  The mixture was stirred at rt for under N2 18 h then all volatiles 
were removed in vacuo to give an oil.  Pure product was obtained by column 
chromatography (increasing polarity from 25 % to 50 % EtOAc in petroleum spirit 
(pet. sp.) as eluant), which gave the title compound (135 mg, 0.322 mmol, 94 %) as a 
clear oil. []D29:  -15 (c 1.0, CHCl3). MS (CI+) m/z 420 (30 %) (M+1), HRMS (CI+) 
found 420.2745, calc for C24H38NO5 420.2750 (M+1). H (300 MHz, CDCl3): 1.10-
1.65 (7H, m, H3, H4, H5 and OH), 1.42 (9H, s, (CH3)3C), 3.41 (2H, br. t, J=6.0 Hz, 
H6), 3.77 (3H, s, OCH3), 3.60-3.84 (3H, m, H2 and H1''), 3.94 (1H, br. t, J=7.5 Hz, 
H1), 4.40 (2H, s, OCH2Ar), 5.02-5.22 (4H, m, H2' and H3''), 5.72-5.96 (2H, m, H1' 
and H2''), 6.84 (2H, d, J=8.7 Hz, 2 x ArCH), 7.23 (2H, d, J=8.7 Hz, 2 x ArCH). C 
(75 MHz, CDCl3):  22.4 (t, C4), 28.3 (q, (CH3)3C), 29.7, 34.2 (t, C3 and C5), 50.0 (br. 
t, C1''), 55.1 (q, OCH3), 65.6 (d, C1), 69.9 (t, C6), 71.9 (br. d, C2), 72.4 (t, OCH2Ar), 
80.2 (s, (CH3)3C), 113.5 (d, 2 x ArCH), 116.6, 117.8 (t, C2' and C3''), 129.0 (d, 2 x 




methoxyphenyl)methoxy]pentyl]-1H-pyrrole-1-carboxylate (5).  
The N-Boc derivative of 4 (500 mg, 1.193 mmol) was dissolved in dry DCM (300 
mL) then benzylidene-bis-(tricyclohexlphosphine)dichlororuthenium (Grubbs' cat.) 
(50 mg, 0.061 mmol) was added.  The mixture was heated to reflux under N2 for 20 h, 
then cooled, before all solvent was removed in vacuo to give an oil.  Pure product was 
obtained by column chromatography (increasing polarity from 25 % to 50 % EtOAc 
in pet. sp. as eluant), which gave the title compound (426 mg, 1.088 mmol, 91.2 %) as 
a clear oil. []D29:  -79 (c 0.9, CHCl3). MS (CI+) m/z 392 (37 %) (M+1), HRMS (CI+) 
 8
found 392.2409, calc for C22H34NO5 392.2437 (M+1). H (300 MHz, CDCl3): 1.48 
(9H, s, (CH3)3C), 1.20-1.73 (6H, m, H2', H3' and H4'), 3.44 (2H, t, J=6.3 Hz, H5'), 
3.56-3.66 (1H, m, H2), 3.79 (3H, s, OCH3), 3.99 (1H, br. d, J=15.7 Hz, H5a), 4.18 
(1H, br. d, J=15.6 Hz, H5b), 4.41 (2H, s, OCH2Ar), 4.54 (1H, m, H1'), 4.96 (1H, br. s, 
OH), 5.60-5.90 (2H, m, H3 and H4), 6.86 (2H, dt, J=8.4, 3.0 Hz, 2 x ArCH), 7.24 
(2H, dt, J=8.4, 3.0 Hz, 2 x ArCH). C (75 MHz, CDCl3):  21.7 (t, C3'), 28.4 (q, 
(CH3)3C), 29.7, 33.3 (C2' and C4'), 53.9 (t, C5), 55.2 (q, OCH3), 70.0 (t, C5'), 70.0 (d, 
C2), 72.4 (t, OCH2Ar), 75.4 (d, C1'), 80.4 (s, (CH3)3C), 113.5 (d, 2 x ArCH), 126.4, 




methoxyphenyl)methoxy]]-3,4-dihydroxy-1-pyrrolidinecarboxylate (6).  
The 2,5-dihydropyrrole 5 (426 mg, 1.088 mmol) was dissolved in acetone (6 mL), 
then water (4 mL), N-methyl-morpholine-N-oxide (269 mg, 2.32 mmol) and 
K2OsO4.2H2O (20 mg, 0.0544 mmol) were added.  The mixture was stirred at rt for 
20 h, then all volatiles were removed in vacuo to give a brown oil.  Pure product was 
obtained by column chromatography (increasing polarity from 2.5 % to 10 % MeOH 
in DCM as eluant), which gave the title compound (442 mg, 1.039 mmol, 95.5 %) as 
a clear oil.  []D27:  -28 (c 1.0, CHCl3). MS (CI+) m/z 426 (100 %) (M+1), HRMS 
(CI+) found 426.2482, calc for C22H36NO7 426.2492 (M+1). H (300 MHz, CDCl3):  
1.40 (9H, s, (CH3)3C), 1.30-1.70 (8H, m, H2', H3', H4' and 2 x OH), 3.30-4.30 (9H, 
m, H2, H3, H4, H5, H1', H5' and OH), 3.78 (3H, s, OCH3), 4.40 (2H, s, OCH2Ar), 
6.84 (2H, d, J=8.4 Hz, 2 x ArCH), 7.23 (2H, d, J=8.4 Hz, 2 x ArCH). C (75 MHz, 
CDCl3):  22.0 (br. t, C3'), 28.1 (q, (CH3)3C), 29.2, 32.7 (t, C2' and C4'), 51.3 (br. t, 
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C5), 54.9 (q, OCH3), 67.0 (br. d, C2), 69.5 (br. d, C4), 69.7 (t, C5'), 72.2 (t, 
OCH2ArCH), 72.9 (br. d, C3), 76.4 (d, C1'), 80.3 (s, (CH3)3C), 113.5 (d, 2 x ArCH), 






The triol 6 (440 mg, 1.034 mmol) was dissolved in THF (60 mL) then NaH (302 mg, 
6.024 mmol, 50 % dispersion in wax), benzylbromide (0.64 mL, 5.50 mmol) and 
nBu4NI (112 mg, 0.30 mmol) were added.  The mixture was stirred at rt under N2 for 
3d then poured into water (50 mL) and extracted with DCM (3 x 40 mL).  The 
combined organic portions were dried (MgSO4), filtered and evaporated in vacuo to 
give an oil.  Pure products were obtained by column chromatography (increasing 
polarity form 20 % to 100 % EtOAc in pet. sp. as eluant), which gave the title 
compound (396 mg, 0.569 mmol, 55 %), and the oxazolidinone (116 mg, 0.218 mmol, 
21 %) as clear oils. 
7: []D30:  -29 (c 3.96, CHCl3). MS (ES+) m/z 696.4 (100 %) (M+1), HRMS (ES+) 
found 696.3895, calc for C43H54NO7 696.3900 (M+1). H (300 MHz, CDCl3):  1.45 
(9H, s, (CH3)3C), 1.20-1.70 (6H, m, H2', H3' and H4'), 3.28-3.43 (3H, m, H5a and 
H5'), 3.52 (1H, br. d, J=6.3 Hz, H5b), 3.78 (3H, s, OCH3), 3.75-3.87 (1H, m, H1'), 
3.87-4.06 (2H, m, H3 and H4), 4.17-4.74 (7H, m, H2 and 3 x OCH2Ph), 4.40 (2H, s, 
OCH2Ar), 6.86 (2H, d, J=9.0 Hz 2 x ArCH), 7.21-7.36 (17 H, m, 2 x ArCH and 3 x 
OCH2Ph). C (75 MHz, CDCl3): two rotamers were evident in equal intensity 
22.9/23.2 (t, C3'), 28.4 (q, (CH3)3C), 29.6 (t, C4'), 30.0/30.4 (t, C2'), 48.8/49.5 (t, C5), 
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55.2 (q, OCH3), 62.5/63.6 (d, C2), 69.9 (t, C5'), 71.2, 71.3/71.8, 72.4, 72.3/72.6 (t, 
OCH2Ar and 3 x OCH2Ph), 75.3/76.3, 76.5/77.8, 78.4/78.6 (d, C3, C4 and C1'), 
79.7/80.0 (s, (CH3)3C), 113.7 (d, ArCH), 127.6, 127.7, 127.7, 128.0, 128.0, 128.2, 
128.2, 128.3, 128.3 (d, 3 x OCH2Ph), 129.1 (d, 2 x ArCH), 130.6 (s, ArCH), 137.6, 
138.0, 138.4 (s, 3 x OCH2Ph), 159.0 (s, 2 x ArCH), 164.0 (s, CO). 
8: []D30:  +28 (c 1.03, CHCl3). MS (ES+) m/z 532.3 (47 %) (M+1), HRMS (ES+) 
found 532.2698, calc for C32H37NO6 532.2699 (M+1). H (300 MHz, CDCl3): 1.40-
1.86 (6H, m, H1', H2' and H3'), 3.37 (1H, dd, J=12.9, 1.5 Hz, H5a), 3.42 (2H, t, J=6.3 
Hz, H4'), 3.53 (1H, dd, 9.0, 4.8 Hz, H7), 3.70-3.80 (2H, m, H5b and H7a), 3.77 (3H, 
s, OCH3), 4.09 (1H, td, J=5.1, 1.5 Hz, H6), 4.22 (1H, ddd, J=7.2, 5.4, 3.6 Hz, H1), 
4.39 (1H, d, J=12.0 Hz, OCH2Ph), 4.41 (2H, s, OCH2Ar), 4.59 (2H, AB system, 
J=12.0 Hz, OCH2Ph), 4.65 (1H, d, J=12.0 Hz, OCH2Ph), 6.86 (2H, dt, J=8.4, 3.0 Hz, 
2 x ArCH), 7.22-7.38 (12H, m, 2 x ArCH and 2 x OCH2Ph). C (75 MHz, CDCl3):  
21.1 (t, C2'), 29.2 (C3'), 35.0 (t, C1'), 50.8 (t, C5), 55.1 (q, OCH3), 65.0 (d, C7a), 69.4 
(t, C4'), 71.9, 72.2, 72.4 (t, OCH2Ar and 2 x OCH2Ph), 75.8, 79.0 (C6 and C7), 81.5 
(d, C1), 113.6 (d, 2 x ArCH), 127.7, 127.9, 127.9, 128.1, 128.4, 128.5 (d, 2 x 
OCH2Ph), 129.1 (d, 2 x ArCH), 130.4 (s, ArC), 137.0, 137.2 (s, 2 x OCH2Ph), 159.0 
(s, ArC), 160.9 (s, C3). 
 
(’S,2R,3R,4S)-1’,3,4-Tris(phenylmethoxy)-2-pyrrolidinepentanol (9). 
The carbamate 7 (396 mg, 0.569 mmol) was dissolved in DCM (5 mL), then TFA (5 
mL) and anisole (0.60 mL, 5.44 mmol) were added.  The mixture was stirred at rt for 
2 h, then all volatiles were removed in vacuo.  The residue was dissolved in CHCl3 
then poured into sat. Na2CO3 solution (5 mL), and extracted with CHCl3 (3 x 25 mL).  
The combined organics were dried (MgSO4), filtered and evaporated in vacuo to give 
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an oil.  Pure product was obtained by column chromatography (increasing polarity 
from 5 % to 15 % MeOH in DCM as eluant), which gave the title compound (260 mg, 
0.547 mmol, 96 %) as a clear oil. []D26:  +81 (c 2.60, CHCl3). MS (ES+) m/z 476.7 
(100 %) (M+1), HRMS (ES+) found 476.2808, calc for C30H38NO4 476.2801 (M+1). 
H (300 MHz, CDCl3):  1.26-1.90 (6H, m, H2', H3' and H4'), 2.96-3.15 (4H, m, H5, 
NH and OH), 3.31 (1H, dd, J=7.5, 2.4 Hz, H2), 3.50 (1H, td, J=7.2, 2.4 Hz, H5'), 3.58 
(2H, t, J=6.3 Hz, H1'), 3.70 (1H, dd, J=7.5 and 5.1 Hz, H3), 3.90 (1H, q, J=4.5 Hz, 
H4), 4.23 (1H, d, J=11.1 Hz OCH2Ph), 4.32 (1H, d, J=11.7 Hz, OCH2Ph), 4.50 (1H, 
d, J=12.0 Hz, OCH2Ph), 4.55 (1H, d, J=11.4 Hz, OCH2Ph), 4.60 (1H, d, J=12.0 Hz, 
OCH2Ph), 4.62 (1H, d, J=12.0 Hz, OCH2Ph), 7.15-7.40 (15H, m, 3 x OCH2Ph). C 
(75 MHz, CDCl3):  21.4 (t, C3'), 30.6, 32.5 (t, C2' and C4'), 49.3 (t, C5), 61.6 (t, C1'), 
63.0 (d, C2), 71.2, 71.9, 72.0 (t, 3 x OCH2Ph), 76.4, 77.5, 79.6 (C3, C4 and C5'), 
127.5, 127.6, 127.6, 127.7, 127.9, 128.0, 128.2, 128.2, 128.2 (d, 3 x OCH2Ph), 137.9, 




The amino alcohol 9 (240 mg, 0.505 mmol) was dissolved in DCM (20 mL) then the 
solution was cooled to 0 oC.  Carbontetrabromide (419 mg, 1.263 mmol), and 
triphenylphosphine (331 mg, 1.263 mmol) were added, then the mixture was stirred 
under N2 for 5 min.  Triethylamine (2.8 mL, 20.09 mmol) was added, then the mixture 
was stirred at 0 oC for 2 h, before being left to stand at 4 oC for 18 h.  The mixture was 
poured into water (50 mL), then extracted with DCM (3 x 40 mL).  The combined 
organic portions were dried (MgSO4), filtered and evaporated in vacuo to give a black 
semi solid.  Pure product was obtained by column chromatography (increasing 
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polarity from 1 % to 5 % MeOH in DCM as eluant), which gave the title compound 
(118 mg, 0.258 mmol, 51 %) as a clear oil. []D27:  +64 (c 1.15, CHCl3). MS (ES+) 
m/z 458.5 (100 %) (M+1), HRMS (ES+) found 458.2694, calc for C30H36NO3 
458.2695 (M+1). H (300 MHz, CDCl3):  1.30-1.46 (1H, m, H7a), 1.56-1.94 (5H, m, 
H6, H7b, H8), 2.51 (1H, ddd, J=11.7, 8.4, 4.8 Hz, H5a), 2.84 (1H, dd, J=9.3, 7.5 Hz, 
H3a), 2.90 (1H, dd, J=3.9, 2.4 Hz, H9a), 3.03 (1H, dt, J=11.7, 5.7 Hz, H5b), 3.22 
(1H, dd, J=9.3, 5.1 Hz, H3b), 3.56 (1H, td, J=5.1, 2.4 Hz, H9), 3.85 (1H, t, J=4.5 Hz, 
H1), 4.02 (1H, dt, J=7.5, 5.1 Hz, H2), 4.22 (1H, d, J=12.0 Hz OCH2Ph), 4.35 (1H, d, 
J=12.0 Hz OCH2Ph), 4.53 (1H, d, J=12.3 Hz OCH2Ph), 4.56 (1H, d, J=12.0 Hz 
OCH2Ph), 4.58 (1H, d, J=12.3 Hz OCH2Ph), 4.59 (1H, d, J=12.0 Hz OCH2Ph), 7.17-
7.42 (15H, m, 3 x OCH2Ph). C (75 MHz, CDCl3):  21.7 (t, C7), 30.0, 31.9 (t, C6 and 
C8), 56.5, 57.9 (t, C3 and C5), 70.5, 71.6, 72.3 (t, 3 x OCH2Ph), 72.3 (d, C9a), 75.9, 
76.8 (d, C1 and C2), 80.4 (d, C9), 127.5, 127.5, 127.7, 127.9, 128.2, 128.2, 128.2, 
128.3, 128.3 (d, 3 x OCH2Ph), 138.5, 138.5, 138.5 (s, 3 x OCH2Ph). 
 
(1R,2S,9S,9aR)-Octahydro-1H-pyrrolo[1,2-a]azepine-1,2,9-triol (11). 
The tri-O-benzyl compound 10 (115 mg, 0.251 mmol) was dissolved in MeOH (4 
mL) then PdCl2 (40 mg, 0.226 mmol) was added and the flask flushed with H2 (g).  
The mixture was stirred at rt under an atmosphere of H2 for 1h, then the flask was 
flushed with N2, before the mixture was filtered through celite.  The solids were 
washed with MeOH (2 x 10 mL), and the combined filtrates were evaporated in 
vacuo. The residue was dissolved in water (2 mL) and applied to Dowex-1 basic ion 
exchange resin (OH- form).  Elution with water (50 mL), followed by evaporation of 
the eluant in vacuo gave the title compound (46 mg, 0.246 mmol, 97.9 %) as a white 
solid. mp. 100-104 oC. []D25:  +60.3 (c 0.46, MeOH). MS (CI+) m/z 188 (100 %) 
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(M+1), HRMS (ES+) found 188.1301, calc for C9H18NO3 188.1287 (M+1). H (300 
MHz, D2O):  1.22-1.38 (1H, m, H7a), 1.42-4.62 (4H, m, H6, H7b and H8a), 1.76-1.88 
(1H, m, H8b), 2.34 (1H, dt, J=12.0, 6.3 Hz, H5a), 2.46 (1H, dd, J=10.2, 6.6 Hz, H3a), 
2.63-2.70 (1H, m, H9a), 2.84 (1H, dt, J=11.7, 5.7 Hz, H5b), 3.00 (1H, dd, J=10.5, 5.4 
Hz, H3b), 3.86-3.97 (3H, m, H1, H2 and H9). C (75 MHz, D2O ref CH3CN):  21.4 (t, 
C7), 29.4, 36.1 (t, C6 and C8), 56.5, 59.7 (t, C3 and C5), 69.6 (d, C9a), 70.8 (d, C9), 
73.6, 74.9 (d, C1 and C2). 
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